Literature DB >> 12193358

Relation of childhood gastrointestinal disorders to autism: nested case-control study using data from the UK General Practice Research Database.

Corri Black1, James A Kaye, Hershel Jick.   

Abstract

OBJECTIVES: To assess whether children with autism are more likely to have a history of gastrointestinal disorders than children without autism.
DESIGN: Nested case-control study.
SETTING: UK General Practice Research Database.
SUBJECTS: Children born after 1 January 1988 and registered with the General Practice Research Database within 6 months of birth. OUTCOME MEASURES: Chronic inflammation of the gastrointestinal tract, coeliac disease, food intolerance, and recurrent gastrointestinal symptoms recorded by the general practitioner.
RESULTS: 9 of 96 (9%) children with a diagnosis of autism (cases) and 41 of 449 (9%) children without autism (matched controls) had a history of gastrointestinal disorders before the index date (the date of first recorded diagnosis of autism in the cases and the same date for controls). The estimated odds ratio for a history of gastrointestinal disorders among children with autism compared with children without autism was 1.0 (95% confidence interval 0.5 to 2.2).
CONCLUSIONS: No evidence was found that children with autism were more likely than children without autism to have had defined gastrointestinal disorders at any time before their diagnosis of autism.

Entities:  

Mesh:

Year:  2002        PMID: 12193358      PMCID: PMC119436          DOI: 10.1136/bmj.325.7361.419

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  17 in total

1.  No evidence for a new variant of measles-mumps-rubella-induced autism.

Authors:  E Fombonne; S Chakrabarti
Journal:  Pediatrics       Date:  2001-10       Impact factor: 7.124

2.  Calcium-channel blockers and risk of cancer.

Authors:  H Jick; S Jick; L E Derby; C Vasilakis; M W Myers; C R Meier
Journal:  Lancet       Date:  1997-02-22       Impact factor: 79.321

Review 3.  The autistic spectrum.

Authors:  L Wing
Journal:  Lancet       Date:  1997-12-13       Impact factor: 79.321

4.  Time trends in autism and in MMR immunization coverage in California.

Authors:  L Dales; S J Hammer; N J Smith
Journal:  JAMA       Date:  2001-03-07       Impact factor: 56.272

5.  Risk of cataract among users of intranasal corticosteroids.

Authors:  L Derby; W C Maier
Journal:  J Allergy Clin Immunol       Date:  2000-05       Impact factor: 10.793

6.  Incidence of first-time idiopathic seizures in users of tramadol.

Authors:  C Gasse; L Derby; C Vasilakis-Scaramozza; H Jick
Journal:  Pharmacotherapy       Date:  2000-06       Impact factor: 4.705

7.  Anticonvulsants and congenital malformations.

Authors:  S S Jick; B Z Terris
Journal:  Pharmacotherapy       Date:  1997 May-Jun       Impact factor: 4.705

8.  Mumps, measles, and rubella vaccine and the incidence of autism recorded by general practitioners: a time trend analysis.

Authors:  J A Kaye; M del Mar Melero-Montes; H Jick
Journal:  BMJ       Date:  2001-02-24

9.  Antihypertensive drugs and the risk of idiopathic aplastic anaemia.

Authors:  M W Myers; C Vasilakis; M R Kaufman; H Jick
Journal:  Br J Clin Pharmacol       Date:  2000-06       Impact factor: 4.335

10.  Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children.

Authors:  A J Wakefield; S H Murch; A Anthony; J Linnell; D M Casson; M Malik; M Berelowitz; A P Dhillon; M A Thomson; P Harvey; A Valentine; S E Davies; J A Walker-Smith
Journal:  Lancet       Date:  1998-02-28       Impact factor: 79.321

View more
  41 in total

1.  Vaccine refusal and the endgame: walking the last mile first.

Authors:  Diane S Saint-Victor; Saad B Omer
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2013-06-24       Impact factor: 6.237

Review 2.  Validity of diagnostic coding within the General Practice Research Database: a systematic review.

Authors:  Nada F Khan; Sian E Harrison; Peter W Rose
Journal:  Br J Gen Pract       Date:  2010-03       Impact factor: 5.386

3.  What Every Behavior Analyst Should Know About the "MMR Causes Autism" Hypothesis.

Authors:  William H Ahearn
Journal:  Behav Anal Pract       Date:  2010

4.  Towards Identifying Genetic Biomarkers for Gastrointestinal Dysfunction in Autism.

Authors:  A E Shindler; E L Hill-Yardin; S Petrovski; N Bishop; A E Franks
Journal:  J Autism Dev Disord       Date:  2020-01

5.  Can urinary indolylacroylglycine levels be used to determine whether children with autism will benefit from dietary intervention?

Authors:  Julie Wilson; Barry Wright; Sandra Jost; Robert Smith; Helen Pearce; Sally Richardson
Journal:  Pediatr Res       Date:  2016-11-23       Impact factor: 3.756

6.  Behavioral Phenotype of ASD Preschoolers with Gastrointestinal Symptoms or Food Selectivity.

Authors:  Margherita Prosperi; Elisa Santocchi; Giulia Balboni; Antonio Narzisi; Margherita Bozza; Francesca Fulceri; Fabio Apicella; Roberta Igliozzi; Angela Cosenza; Raffaella Tancredi; Sara Calderoni; Filippo Muratori
Journal:  J Autism Dev Disord       Date:  2017-11

7.  Bone Mineral Density in Boys Diagnosed with Autism Spectrum Disorder: A Case-Control Study.

Authors:  Kelly Barnhill; Lucas Ramirez; Alan Gutierrez; Wendy Richardson; C Nathan Marti; Amy Potts; Rebeca Shearer; Claire Schutte; Laura Hewitson
Journal:  J Autism Dev Disord       Date:  2017-11

8.  Development and validation of an inventory to assess mealtime behavior problems in children with autism.

Authors:  Colleen Taylor Lukens; Thomas R Linscheid
Journal:  J Autism Dev Disord       Date:  2007-06-20

9.  Rigid-compulsive behaviors are associated with mixed bowel symptoms in autism spectrum disorder.

Authors:  Brittany Peters; Kent C Williams; Phillip Gorrindo; Daniel Rosenberg; Evon Batey Lee; Pat Levitt; Jeremy Veenstra-VanderWeele
Journal:  J Autism Dev Disord       Date:  2014-06

Review 10.  Validation and validity of diagnoses in the General Practice Research Database: a systematic review.

Authors:  Emily Herrett; Sara L Thomas; W Marieke Schoonen; Liam Smeeth; Andrew J Hall
Journal:  Br J Clin Pharmacol       Date:  2010-01       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.